Molecular Docking and<i> In Silico</i> ADMET Study Reveals Acylguanidine 7a as a Potential Inhibitor of <i>β</i>-Secretase

<div>The APP processing (in brief): APP: amyloid precursor protein; sAPP: soluble APP fraction; A<i>β</i>: amyloid beta; C-portion: C-terminal portion obtained from final cleavage.</div>

Advances in Bioinformatics

fig1

Figure 1

Figure 1: Molecular Docking and<i> In Silico</i> ADMET Study Reveals Acylguanidine 7a as a Potential Inhibitor of <i>β</i>-Secretase 

Advances in Bioinformatics

Molecular Docking and In Silico ADMET Study Reveals Acylguanidine 7a as a Potential Inhibitor of β-Secretase

Figure 1